Clinical trial looks at tramadol for opioid withdrawal: JAMA Psychiatry supriya kashyap kashyap16 July 2017 9:58 AM ISTA randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of...
Inj. Sublocade - first once a month buprenorphine for opioid use disorder Dr. Kamal Kant Kohli Kohli4 Dec 2017 7:10 PM ISTThe U.S. Food and Drug Administration approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of...
Slow-release oral morphine a new option for treating opioid abuse Anjali Nimesh Nimesh26 Dec 2017 7:22 PM ISTSlow-release oral Morphine (SROM) has emerged as a promising candidate for oral opioid agonist therapy. However, more research is needed before it can...
Buprenorphine may cause breathing problems in patients taking it for opioid abuse Anjali Nimesh Nimesh3 Feb 2018 7:10 PM ISTBuprenorphine is a Schedule III drug and belongs to group of three drugs approved by the US Food and Drug Administration for patients undergoing...
Buprenorphine-naloxone preferred first-line treatment for opioid use disorder -Canadian guidelines Anjali Nimesh Nimesh6 March 2018 7:20 PM ISTA new Canadian guideline for managing opioid use disorders has been released.This has been created for a wide range of healthcare providers to address...
New Canadian guidelines on managing opioid use disorders Dr. Kamal Kant Kohli Kohli18 March 2018 7:30 PM ISTOpioid use disorder is one of the most challenging forms of addiction facing the Canadian health care system, and a major contributor to the marked...
FDA approves new dosage of buprenorphine and naloxone for opioid dependence Hina Zahid8 Sept 2018 7:20 PM ISTThe U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
Investigational Tx Shows Promise in Chronic Low Back Pain Vinay Singh singh24 Sept 2018 7:15 PM ISTPositive top-line results were announced for a Phase 3 study of CAM2038 for the treatment of moderate-to-severe Chronic Low Back Pain (CLBP) in...
Opioid use increases hip fracture risk among Alzheimer's disease patients Hina Zahid1 Dec 2018 7:20 PM ISTA Study of the University of Eastern Finland shows that Alzheimer's disease patients using opioids have twice the risk of hip fracture compared to...
Buprenorphine best option for treating neonatal abstinence syndrome: JAMA Medha Baranwal Baranwal24 Jan 2019 7:28 PM ISTNova Scotia, Canada: A new study suggests that Buprenorphine may be the optimal pharmacological treatment for neonatal abstinence syndrome (NAS).The...
Never substitute any analgesic for buprenorphine in patients with opioid use disorder: Case report Deepanjana Sarkar28 Aug 2019 7:05 PM ISTContinue outpatient buprenorphine treatment for patients with opioid use disorder admitted with acute pain, suggests a case study published in the...
